Financial Industry News November 16th News This evening, I will take a look at the important announcements tonight - Hainan Rubber plans to acquire 36% of HAC Company's shares to expand the international processing production capacity and trade scale; Visual China related AI content business is still in its early stages; ST Shuguang has not had any form of contact with Huawei and Xiaomi...
[Major matters]
Hainan Rubber (601118) announced on the evening of November 16th that the company plans to pay cash to acquire 574 million issued common shares of HAC Company held by Sinochem New through overseas SPV, accounting for about 36% of HAC's issued common shares, with a purchase price of US$0.315 per share, and a transaction consideration of US$181 million. Sinochem Xin is a wholly-owned subsidiary of Sinochem International (600500). After the transaction is completed, Hainan Rubber will become the indirect controlling shareholder of HAC Company, and can quickly obtain the overseas processing capacity of natural rubber and latex; it will use HAC Company's European and American trade network to further enter the global natural rubber trade; it will obtain HAC Company's natural rubber plantations in emerging natural rubber production areas such as Cameroon and Côte d'Ivoire . After the completion of this share transfer, it will trigger the obligation to acquire by . Overseas SPV will initiate a compulsory tender offer to acquire all the remaining shares of HAC Company at the same price as for the same price as agreement, and ultimately hold up to 70.8% of HAC Company's shares.
Vision China: The related AI content generation business is still in its early stages
Vision China (000681) issued an abnormal announcement on the evening of November 16. Recently, in the A-share market has paid a lot of attention to AIGC-related concepts. The company's meta-visual platform has issued digital artworks generated by AI. The company's related AI content generation business is based on the company's existing massive data and commercial application scenarios, as well as the accumulation of AI technology. Through big data analysis and learning, it is completed by photographers, designers and AI in the company's communities. The company's related business is still in its early stages and is expected to have a significant impact on the company's financial situation in the short term.
ST Dawn: No contact with Huawei and Xiaomi
ST Dawn (600303) issued a risk warning on the evening of November 16. There is a great uncertainty about whether the equity auction of the company's controlling shareholder can be launched, and the relevant equity auction of the second largest shareholder was withdrawn. Huawei and Xiaomi have never had any form of contact with the company. Ganfeng Lithium Company has only business cooperation with the company and has not made any form of contact with any other matters. The relevant market rumors are completely false information.
Sanfu Xinke: Zhidian is expected to purchase a batch of composite copper foil production equipment from the company for the first phase
Sanfu Xinke (688359) announced on the evening of November 16 that the company and Zhidian signed a strategic cooperation framework agreement. Zhidian is expected to purchase "one-step" fully wet composite copper foil electroless copper plating equipment from the company for the first phase, with the estimated total amount (including tax) not exceeding 320 million yuan. The company will carry out new business in the research and development, production and sales of composite copper foil production equipment, provide supporting production equipment for the promotion of the company's special chemicals for electroplating of composite copper foils, and provide downstream customers with one-stop technical solutions for composite copper foil manufacturing. Up to now, the company's composite copper foil production equipment is in the pilot stage.
Jingao Technology: It plans to build an integrated intelligent factory and R&D center of photovoltaic slice, battery and module for 10.2 billion yuan and a R&D center of
Jingao Technology (002459) announced on the evening of November 16 that its wholly-owned subsidiary Jingao Solar Energy , Shijiazhuang Municipal Government and Shijiazhuang High-tech Industrial Development Zone Management Committee signed a "Project Cooperation Framework Agreement". The company plans to build a integrated intelligent factory and R&D center project of photovoltaic slicing, battery and module in Shijiazhuang High-tech Industrial Development Zone , with a total investment of approximately 10.2 billion yuan.
Jingyeda: The two shareholders sold a total of 993,900 shares of
Jingyeda issued an abnormal announcement, and the company's specific shareholder Ruiying Technology sold 2.5198 million shares of Jingyeda shares on November 16. Ruiying Technology's share reduction has been completed, and there is no plan to reduce its shareholding in Jingyeda stocks. Ruifeng Technology, a specific shareholder of the company, sold 474,100 shares of Jingyeda shares on November 16. According to this share reduction plan, Ruifeng Technology will also continue to reduce its holdings of Jingyeda shares by no more than 121,000 shares through centralized bidding transactions.
Erkang Pharmaceutical: It plans to invest 1 billion yuan in lithium carbonate and its preparation projects
Erkang Pharmaceutical (300267) announced on the evening of November 16 that the company plans to raise 1 billion yuan in self-funded investment in the construction of lithium carbonate and its preparation projects, with the construction cycle (including debugging) expected to be 6 months. Lithium carbonate is one of the important drugs for treating mania, bipolar disorder manic episodes, and schizophrenia . In addition, lithium carbonate is also widely used in the livestock industry, new energy and chemical industry.
Sichuan Investment Energy : The company's chairman Liu Tibin was investigated
Sichuan Investment Energy (600674) announced on the evening of November 16 that Liu Tibin, chairman of the company's controlling shareholder, has been investigated and implemented by the Sichuan Provincial Supervision Commission. Liu Tibin also serves as the company's legal representative and chairman. This matter will not have a significant impact on the company's daily business activities.
[Real performance express]
Jinhui Co., Ltd.: Release profit distribution plan for the first three quarters, and plans to pay 1.84 yuan for 10
Jinhui Co., Ltd. (603132) on the evening of November 16, and plans to pay a cash dividend of 1.84 yuan (including tax) to all shareholders for every 10 shares, and a total of 180 million yuan (including tax) will be paid.
[Mergers and Acquisitions]
Jingcheng Shares: The private placement raises no more than 1.172 billion yuan. It plans to acquire 100% of the equity of Beiren Intelligent
Jingcheng Shares (600860) announced on the evening of November 16 that the private placement raises no more than 1.172 billion yuan. It will be used for the hydrogen energy cutting-edge technology industry development project, intelligent manufacturing industrial park project, acquisition of 100% of the equity of Beiren Intelligent and supplement working capital. The company's controlling shareholder and actual controller, Jingcheng Mechanical and Electrical, plans to subscribe for the amount of this private placement of no less than 250 million yuan. Beiren Intelligent is a wholly-owned subsidiary of the company's controlling shareholder. The transaction price of 100% equity of Beiren Intelligent is no more than 420 million yuan. This acquisition can allow the company to use this to layout the intelligent printing equipment industry.
Notel Bio: It plans to issue convertible bonds of no more than 534 million yuan for raw materials and other projects
Notel Bio (688076) announced on the evening of November 16 that the company plans to issue convertible bonds to unspecified objects to raise no more than 534 million yuan for investment in raw material product research and development projects, raw material manufacturing and green production improvement projects, oligonucleotide monomer industrialization production projects and supplement working capital.
[Increase and reduce holdings]
Juyi Technology: It plans to repurchase shares for 70 million yuan to 120 million yuan
Juyi Technology (688162) announced on the evening of November 16 that the company plans to repurchase shares for 70 million yuan to 120 million yuan, with the repurchase price not exceeding 70 yuan per share. The shares repurchased this time are intended to be used to implement equity incentives or employee stock ownership plans.
Guizhou Tire: It plans to repurchase shares from RMB 70 million to RMB 120 million
Guizhou Tire (000589) announced on the evening of November 16 that the company plans to repurchase the company's shares through centralized bidding transactions, and the repurchased shares are intended to be used for equity incentive plans. The price of shares repurchased this time is no more than 6.18 yuan per share, and the total amount of repurchased funds is no less than 70 million yuan and no more than 120 million yuan.
Bailong Chuangyuan: Qingdao Kaijin and its joint actors plan to reduce their holdings of no more than 7.89% of the shares
Bailong Chuangyuan (605016) announced on the evening of November 16 that the shareholders of total , Qingdao Kaijin, and the joint actors Jiaxing Kaijin and Guo Enyuan, planned to reduce their holdings of no more than 7.89% of the company's shares.
Baiao Intelligent: Dachen Chuangfeng plans to reduce its holdings of the company by no more than 4%
Baiao Intelligent (300836) announced on the evening of November 16 that the shareholders of Shenzhen Dachen Chuangfeng Equity Investment Enterprise (Limited Partnership) plans to reduce its holdings of the company by no more than 2.5613 million shares through centralized bidding or bulk transactions, that is, no more than 4% of the company's total share capital.
Shanghai Xiba: The controlling shareholder and its joint actors plan to reduce their holdings of no more than 6% of the shares
Shanghai Xiba (603200) announced on the evening of November 16 that the company's controlling shareholder, chairman and general manager Wang Wei, and his joint actors Shanghai Chengxu Equity Investment Management Partnership (Limited Partnership), Shanghai Huixu Equity Investment Management Partnership (Limited Partnership), Yinwan Quanying No. 17 Private Securities Investment Fund plans to reduce its holdings of no more than 10.3653 million shares of the company, accounting for 6% of the company's total share capital.
Zhongwei Company : Directors, Supervisors and Senior High School plans to reduce their holdings by no more than 2.528 million shares of the company
Zhongwei Company (688012) announced on the evening of November 16 that the company recently received letters of intent to reduce holdings by Yin Zhiyao, Du Zhiyou, Ni Tuqiang, Chen Weiwen, Liu Xiaoyu, and Wang Zhijun respectively. Due to personal financial needs, the above-mentioned reduction entity plans to reduce its holdings by no more than 2.528 million shares through centralized bidding and other means within 6 months after 15 trading days.
Jianlong Micronano : CSI Kaiyuan and its joint actors plan to reduce their holdings of no more than 3%
Jianlong Micronano (688357) announced on the evening of November 16 that CSI Kaiyuan and its joint actors plan to reduce their holdings of no more than 3% of the company's shares.
COSCO Hsingte: Qianhai Kaiyuan plans to reduce its holdings of the company by no more than 3%
COSCO Hsingte (600428) announced on the evening of November 16 that Qianhai Kaiyuan, a shareholder holding 4.63% of the shares, plans to reduce its holdings of the company by no more than 3%.
Meihao Real Estate: The controlling shareholder plans to reduce his holdings of the company by no more than 2.43% of the shares
Meihao Real Estate (000667) announced on the evening of November 16 that the controlling shareholder Meihao Future Enterprise Management Group Co., Ltd. (referred to as " Meihao Group ") plans to reduce his holdings of the company by no more than 60 million shares through centralized bidding and/or bulk transactions (not exceeding 2.43% of the company's total share capital). This share reduction plan will not lead to a change in the company's control.
Fubon Shares : The actual controller's joint activist intends to reduce its holdings of no more than 1% of the shares
Fubon Shares (300387) announced on the evening of November 16 that Wuhan Changjiang Chuangfu Investment Co., Ltd., the company's joint activist, plans to reduce its holdings of the company's shares by no more than 2.8906 million shares (accounting for 1% of the company's total share capital) through centralized bidding or bulk transactions.
Huakaiyibai: The company's directors plan to reduce their holdings of shares
Huakaiyibai (300592) announced on the evening of November 16 that Wang Anqi, the company's director and board secretary, plans to reduce his holdings of the company's shares by no more than 187,500 shares, that is, no more than 0.0669% of the total number of shares of the company.
[Other matters]
Landi Group : The stakeholder company Ningsi Electronics Science and Technology Innovation Board is listed on the Shanghai Stock Exchange Science and Technology Innovation Board
Landi Group (603726) announced on the evening of November 16 that the stakeholder Ningsi Electronics initial public offering shares was listed on the Shanghai Stock Exchange Science and Technology Innovation Board on November 16, 2022. Currently, the company holds 31 million shares of Ningsi Electronics, accounting for 7.6% of its total share capital after the initial public offering.
Fuyuan Pharmaceutical: Compound α-ketolic acid tablets passed the generic consistency evaluation
Fuyuan Pharmaceutical (601089) announced on the evening of November 16 that Compound α-ketolic acid tablets obtained the consistency evaluation of the generic quality and efficacy consistency. The drug is used to "combined with a low-protein diet to prevent and treat damage caused by protein metabolism disorders caused by chronic renal insufficiency."
Renfu Pharmaceutical: Withdrawal of the drug registration application for isoflurane injection and was approved
Renfu Pharmaceutical (600079) announced on the evening of November 16 that its holding subsidiary Yichang Renfu received the "Notice of Termination of Drug Registration Application" by the State Food and Drug Administration on Yichang Renfu voluntarily withdrawing the registration application for isoflurane injection. Isoflurane injection is suitable for the induction of general anesthesia . Yichang Renfu adjusted the research plan in accordance with the latest guiding principles reviewed by the State Food and Drug Administration and voluntarily withdrew the registration application for this product. In the future, Yichang Renfu will comprehensively evaluate the cycle, cost and market demand required for supplementary research of this product, and determine the supplementary research of this product, registration and declaration and other matters.
Hengrui Medicine: The subsidiary obtained the approval notice for drug clinical trials
Hengrui Medicine (600276) announced on the evening of November 16 that its subsidiary Shanghai Hengrui obtained the approval notice for drug clinical trials of SHR-7367 injection, and SHR-7367 injection is intended to be used to treat advanced malignant tumors. The subsidiary Shandong Shengdi obtained a notice of approval for clinical trials of HRS-1358 tablets and HRS-1780 tablets. HRS-1358 tablets can inhibit the proliferation of tumor cells. HRS-1780 is an oral small molecule drug that is clinically intended to treat chronic renal diseases.
Tengda Construction : Winning the bid for a project of 45.2653 million yuan
Tengda Construction (600512) announced on the evening of November 16 that the company won the bid for the "Unified Beiyuan Gardening and Nanyuan Municipal Supporting Project in Hongjia Street, Jiaojiang District, Zhejiang Province" project, with a winning bid of 45.2653 million yuan, with a construction period of 370 days.
Chenxin Pharmaceutical : Enoxaparin sodium injection, etc., obtained the drug registration certificate
Chenxin Pharmaceutical (603367) announced on the evening of November 16 that it received the drug registration certificate for Enoxaparin sodium injection and the drug registration certificate for Valsartan amlodipine tablets (I) approved by the State Food and Drug Administration. Enoxaparin sodium is a low molecular weight heparin preparation and is an antithrombotic drug; Valsartan amlodipine tablets (I) are suitable for primary hypertension patients with hypertension who cannot effectively control it by single-agent treatment.
Shenma Electric Power: It plans to establish an overseas wholly-owned subsidiary in the United States
Shenma Electric Power (603530) announced on the evening of November 16 that it plans to establish an overseas wholly-owned subsidiary in the United States through its Singapore subsidiary Shenma Electric Power Co., Ltd. (Proposed), with a total investment of US$3.8 million. The establishment of a US company will help the company establish a localized marketing layout in North America, with the main business of selling the company's main products.
Huadian Heavy Industry : Signing the PC general contract for the new energy hydrogen production project demonstration project
Huadian Heavy Industry (601226) announced on the evening of November 16 that the company and Inner Mongolia Huadian Hydrogen Energy Technology Co., Ltd. signed the "Hydrogen Station Part of the 200,000 KiloW New Energy Hydrogen Production Project 200,000 Kilometers New Energy Hydrogen Production Project Demonstration Project in Damao Banner, Inner Mongolia Huadian Baotou City, with the contract amount of 345 million yuan and will be put into production within 2023.
Dajia Weikang: It plans to acquire 85.71% of the shares of Tianji Caotang Pharmaceutical Company
Dajia Weikang (301126) announced on the evening of November 16 that the company recently signed a framework agreement for the intention of the share acquisition, intending to acquire 85.7143% of the shares of Hunan Tianji Caotang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianji Caotang") and become the controlling shareholder of Tianji Caotang. Tianji Caotang is currently a listed company on the Innovation Layer of the New Third Board, mainly engaged in the research and development, manufacturing and sales of Chinese patent medicines. This transaction is to further expand the upstream of industry chain , and on the basis of the company already having drug wholesale and retail and specialized hospitals, it has the ability to independently develop and produce drugs.
Chongqing Steel : The company's chairman and some senior executives resigned
Chongqing Steel (601005) announced on the evening of November 16 that due to work adjustments, Zhang Wenxue resigned from the company's chairman, director and strategic committee of the board of directors. The company also received written resignation reports submitted by director and president Xie Zhixiong and senior vice president Meng Wenwang.
Tianan New Materials: The case of private lending dispute suing Evergrande Real Estate Group Zhengzhou Company has been filed and accepted
Tianan New Materials (603725) announced on the evening of November 16 that the case of private lending dispute suing Evergrande Real Estate Group Zhengzhou Company has been filed and accepted by the court. The amount of litigation request is temporarily calculated as of November 2, 2022, totaling 61.9744 million yuan.
Ciwen Media : Co-developing the meta-universe video content ecosystem with Xiaopai Technology
Ciwen Media (002343) announced on the evening of November 16 that the company and Xiaopai Technology (Shanghai) Co., Ltd. agreed to build a cooperative relationship in the fields of meta-universe ecological content and other fields, and recently signed a strategic cooperation framework agreement. Xiaopai Technology uses the ability of metaverse hardware and ecology to continuously develop, and works with Ciwen Media to create metaverse ecological products, and promote Ciwen Media to introduce and apply VR and other related technologies in film and television content production; the two parties jointly promote the construction of VR video creation platforms, gathering VR content production companies, VR technology companies, and VR content creators to jointly develop the metaverse video content ecosystem.
Xiamen Port: The holding company plans to invest 147 million yuan in grain warehouse
Xiamen Port (000905) announced on the evening of November 16 that Xiamen Hailong Port Co., Ltd., a wholly-owned subsidiary of the company's holding subsidiary Xiamen Port Group Shihushan Terminal Co., Ltd., plans to invest in the construction of a new 6# grain warehouse in berth 20-21# berth in the 20-21# berth in the Haicang Port District of Xiamen Port, with a total warehouse capacity of about 70,000 tons and a total investment scale of about 147 million yuan.
Xianhui Technology: The total amount of various contracts received by CATL is approximately RMB 755 million
Xianhui Technology (688155) was announced on the evening of November 16 that since August 31, 2022, the company and Fujian Dongheng have received a total of approximately RMB 755 million in various contracts and designated notices received by CATL and its holding subsidiaries. If the sales contract is successfully performed, it is expected to have a positive impact on the company's 2022-2023 performance.
Aikelan : In the non-road national fourth field, it has carried out project cooperation with many leading customers
Aikelan (300816) disclosed an announcement of abnormal stock trading on the evening of November 16. At present, in the non-road national fourth field, the company has carried out project cooperation with many leading customers such as Quanchai Power, Yuchai Shares, Deutz, and Huafeng Power, and some projects have begun mass production. On November 10, local time, European Commission announced the proposal for "Europe's Phase 7 Emission Standard" (Europe 7) on its official website. At present, no relevant national seven policies have been issued in China. Investors are asked to invest rationally and pay attention to risks.
Hisco : Phase II clinical trial of innovative drug HSK31858 tablets obtained ethical approval
Hisco (002653) announced on the evening of November 16 that the clinical study of the company's innovative drug HSK31858 tablets "a multi-center, randomized, double-blind, placebo-controlled Phase II study that evaluates the effectiveness and safety of HSK31858 tablets in patients with noncystic fibrotic bronchodilation (NCFBE)" was ethical approval from the Medical Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University. Up to now, no drug with the same target has been approved for marketing in the world.
Qicai Chemical: Fit a joint venture to invest in the construction of the 180,000-ton battery-grade Prussian Blue (white) project
Qicai Chemical (300758) announced on the evening of November 16 that the company and Meilian New Materials plan to jointly invest in the establishment of Liaoning Meicai New Materials Co., Ltd., and use the company as the main body to invest 2.5 billion yuan to build a 180,000-ton battery-grade Prussian Blue (white) project. The company's registered capital is 500 million yuan, of which the company plans to invest 245 million yuan, accounting for 49%; Million New Materials plans to invest 255 million yuan, accounting for 51%. This investment will help promote the industrial development of sodium ion batteries.
ST Haiyue: The company's stock application to withdraw other risk warnings
ST Haiyue (600387) announced on the evening of November 16 that the company's stock application to withdraw other risk warnings. The Shanghai Stock Exchange will decide whether to cancel other risk warnings for the company's stock within 10 trading days after receiving the company's application.
Yingjixin: The subsidiary plans to invest 400 million yuan in the Greater Bay Area Integrated Circuit Industrial Park project
Yingjixin (688209) announced on the evening of November 16 that the company's wholly-owned subsidiary Zhuhai Yingjixin plans to invest in the Greater Bay Area Integrated Circuit Industrial Park project with a total amount of 400 million yuan, of which 200 million yuan is planned to use 200 million yuan to customize office buildings, factories and parking spaces in the Beiwei area of the Tangjiawan main park of Zhuhai High-tech Zone to Zhuhai High-tech Construction Investment Co., Ltd., which is responsible for the development and construction of Zhuhai High-tech Zone.
Fengshan Group : The subsidiary has strategic cooperation with Zhongnao Technology and plans to promote the commercial application of sodium ion secondary batteries
Fengshan Group (603810) announced on the evening of November 16 that the holding subsidiary Jiangsu Fengshan Quannuo New Energy Technology Co., Ltd. and Jiangsu Zhongnao Energy Technology Co., Ltd. signed a "Strategic Cooperation Agreement", and the two parties intend to jointly promote the commercial application of sodium ion secondary batteries.
BOE A: It plans to increase investment of 200 million yuan in the equity-controlled company's equity-controlled company
BOE A (000725) announced on the evening of November 16 that Beijing Electric Control Industry Investment Co., Ltd. (hereinafter referred to as "Electronic Controlled Industry Investment") is the company's equity-controlled company. Due to business development needs, Electronic Control Industrial Investment plans to raise 600 million yuan. Electronic Control Industrial Investment's existing shareholders Beijing Electronic Control, BOE and Electronic City plan to increase their capital at the same price and proportion, of which BOE invested 200 million yuan.
Shen Property A: The subsidiary won the right to use a plot in Yangzhou for 179 million yuan
Shen Property A (000011) announced on the evening of November 16 that the holding subsidiary Yangzhou Wuhe Real Estate Co., Ltd. publicly won the right to use the state-owned land in the land GZ399, Pingshan Township, Yangzhou City for a transaction price of 179 million yuan.
China Pacific Insurance : The subsidiary's cumulative original insurance business revenue of 346.93 billion yuan in the first 10 months
China Pacific Insurance (601601) announced on the evening of November 16 that from January to October 2022, the company's subsidiary Pacific Life Insurance Company had a cumulative original insurance business revenue of 202.826 billion yuan, and increased by 25.7% year-on-year; the subsidiary Pacific Property Insurance Company had a cumulative original insurance business revenue of 144.104 billion yuan, a year-on-year increase of 12.1%.
Nenghui Technology: Pre-winning household photovoltaic project
Nenghui Technology (301046) announced on the evening of November 16 that the consortium formed by the company and its wholly-owned subsidiary Guizhou Nenghui is the first winning candidate for "Segment (Contract) [001] Danzhou County Promotion Project (Phase I) Dongcheng Town and other 7 towns household photovoltaic project design and construction general contracting (EPC)". The winning bid price is 3.948 (yuan/Wp), and the estimated investment in project is 389 million yuan.
Ningbo Shipping: It plans to purchase and build 2 85,000-ton bulk carriers
Ningbo Shipping (600798) announced on the evening of November 16 that the company plans to purchase and build 2 85,000-ton bulk carriers in China, with the expected total investment of the project not exceeding 500 million yuan (the investment amount of a single ship shall not exceeding 250 million yuan).
Yongxing Materials: The holding subsidiary lithium-ion battery project is fully put into production
Yongxing Materials (002756) announced on the evening of November 16 that the ultra-wide temperature zone ultra-long life lithium-ion battery project of the company's holding subsidiary Huzhou Yongxing Lithium Battery Technology Co., Ltd. is fully put into production, and will participate in the construction of Ningbo Langchen New Energy Co., Ltd. 50MW/100MWh independent energy storage power station project (referred to as the "Langchen Project"). Yongxing lithium battery is responsible for the design, manufacturing and supply of 5MW/10MWh lithium titanate prefabricated chambers and auxiliary equipment in the project.
Snowman Co., Ltd.: Signed a strategic cooperation agreement with Japan Hydrogen Power Company
Snowman Co., Ltd. (002639) announced on the evening of November 16 that the company signed a strategic cooperation agreement with Japan Co., Ltd. (hereinafter referred to as "Hydrogen Power Company") on the same day. The two parties will conduct close cooperation in the research and development, industrialization, marketing promotion and other aspects of hydrogen fuel cell stack technology. The two sides will jointly promote the industrialized manufacturing project of hydrogen fuel cell stacks in China and accelerate the rapid development of the company's hydrogen energy business.
Jincheng Pharmaceutical : Ritazodone dry suspension project completed Phase I clinical trials
Jincheng Pharmaceutical (300233) announced on the evening of November 16 that the company recently received a notice from its holding subsidiary Guangdong Jincheng Jinsu Pharmaceutical that its subsidiary Guangdong Saifalo Pharmaceutical's ritazodone dry suspension (LT-01) project completed Phase I clinical research trials. Ritazodone is the first new antibiotic-class drug developed by the company, which helps solve the problem of Gram-positive bacteria resistance and has great clinical value.
Xinyada: The company has not carried out specific Web3.0 business
Xinyada (600571) issued a risk warning announcement on the evening of November 16. Recently, it was rumored that the company was involved in the development of Web3.0 business. As of now, the company has not carried out specific Web3.0 business and has not formed any sales revenue. The company's stock price has fluctuated significantly recently, and the short-term increase in the stock price is significantly higher than the Shanghai Composite Index during the same period, but the company's fundamentals have not changed significantly.
Weiye Co., Ltd.: The holding subsidiary won a bid for a construction project of 573 million yuan for
Weiye Co., Ltd. (300621) announced on the evening of November 16 that the holding subsidiary Jiantai Construction Co., Ltd. won the bid for the main construction project of the 109-acre project in Sansheng Township, Chengdu, with a winning amount of approximately 573 million yuan.
Priligy Pharmaceutical: Vancomycin hydrochloride for injection has obtained the marketing authorization of Health Canada
Priligy Pharmaceutical (300630) announced on the evening of November 16 that the company received the marketing authorization of 5g and 10g of vancomycin hydrochloride for injection issued by Health Canada. Vancomycin hydrochloride is used to treat serious infections caused by methicillin-resistant (β-lactam)-resistant Staphylococcus sensitive strains.
Beixin Road and Bridge : The consortium led by the subsidiary won the bid for a project of 431 million yuan for
Beixin Road and Bridge (002307) announced on the evening of November 16 that the consortium formed by the subsidiary Corps Communications Construction (leader) and Shandong Tongzhou Engineering Consulting Co., Ltd. won the bid for the Wutai Calcium-based New Materials Economic Circulation Industry Demonstration Base in Bole City, Bozhou, Xinjiang Uygur Autonomous Region--Logistics Park Outdoor Overall (Second Section) Project (EPC Model) with a winning amount of 431 million yuan. The project construction period is 910 days.
Chujiang New Materials: Planning the third-generation semiconductor special carbon-based materials and equipment project
Chujiang New Materials (002171) announced on the evening of November 16 that recently, media reported that Dai Yu, chairman of the company's holding subsidiary Dingli Technology, participated in the "Investment Conference on the Construction of the Central Committee of the China Democratic League to Help the Modernization of New Hunan" and signed a contract with the "third-generation semiconductor special carbon-based materials and equipment project". After verification: Dai Yu, chairman of Dingli Technology, attended the investment promotion conference jointly organized by the Central Committee of the China Democratic League and the Hunan Provincial Government on November 8. A collective signing ceremony was held at the meeting, intending to plan and build a third-generation semiconductor special carbon-based materials and equipment project, but no formal agreement has been signed yet and the investment amount has not yet been determined. The above-mentioned projects are still in the preliminary planning and demonstration stage, and there is certain uncertainty.
Ocean King: The actual controller of the company, Zhou Mingjie, passed away
Ocean King (002724) announced on the evening of November 16 that Zhou Mingjie, the controlling shareholder, actual controller and chairman of the company, unfortunately passed away at 6:01 on November 16, 2022 due to ineffective treatment of illness at the age of 65. Zhou Mingjie directly holds 507 million shares of the company, accounting for 65.02% of the company's total shares. The company shares held by Zhou Mingjie will go through the inheritance procedures in accordance with laws and regulations.
Mike Bio: Four kits obtained product registration certificates
Mike Bio (300463) announced on the evening of November 16 that the company recently received the " Medical Device Registration Certificate " from four kits including the Type B Natriuretic Peptide Assay Kit (Direct Chemiluminescence Method) issued by the Sichuan Provincial Drug Administration. The above kits are all new products of the company's acridine ester direct chemiluminescence technology platform.
Libert: The subsidiary won the bid for a project mechanical and electrical installation project of 181 million yuan
Libert (605167) announced on the evening of November 16 that the subsidiary Libert Construction won the bid for Yabao's annual production of 50,000 tons of lithium hydroxide lithium battery material project A8XZ-40-K022 wet method area and some public engineering mechanical and electrical installation section projects. The winning amount was RMB 181 million (tax included). Yabao Sichuan’s annual production of 50,000 tons of lithium hydroxide lithium battery material project is expected to be completed and put into production in 2024. After production, it can achieve an annual production capacity of 50,000 tons of lithium hydroxide. The lithium materials produced can meet the power needs of 1.5 million new energy vehicles.
Slake: The controlling shareholder intends to agree to transfer 5% of the company's shares
Slake (300382) announced on the evening of November 16 that the controlling shareholder Koleis Co., Ltd. intends to transfer 31.33 million shares of the company's shares to Suzhou Chendao Jinxin Equity Investment Partnership (Limited Partnership) at a price of 18.53 yuan per share, accounting for 5% of the company's total share capital, and the total transfer price is 581 million yuan. This change in equity did not lead to changes in the company's controlling shareholder and actual controller.
Shensanda A: Not directly engaged in the production and sales of products in related fields such as display panels
Shensanda A (000032) disclosed an announcement of stock trading abnormalities on the evening of November 16. The company's current main business includes two categories: digital and information service business and industrial service business. The company's industrial service business mainly provides industrial engineering services with clean room consultation, design, construction, operation and maintenance as the core for customers in the display panel, integrated circuit, biomedicine, new energy and other industries. The company is not directly engaged in the production or sales of products in the display panel, integrated circuit, biomedicine, new energy and other related fields.
Subway Design: Winning a 1.25 billion yuan contract energy management model project
Subway Design (003013) announced on the evening of November 16 that the company won the bid for the pilot application of the contract energy management model project of the environmental control system of Guangzhou Line 3 and 5, with a total winning price of 1.25 billion yuan, accounting for 52.49% of the company's operating income in 2021. The contract term is 16 years from the date of signing the contract (including 2 years of renovation).
Hanyu Pharmaceutical: The raw materials for desmopressin acetate obtained the EU CEP certificate
Hanyu Pharmaceutical (300199) announced on the evening of November 16 that on November 15, the company's raw materials for desmopressin acetate received the CEP (European Pharmacopeia Applicability Certification) certificate issued by the European Medicines Quality Administration , opening up access channels for the company's desmopressin acetate (raw materials) to enter the EU market. Desmopressin acetate is a cyclic nopolypeptide, a chemically synthesized vasopressor analog, which is a blood vessel shrinking drug among vasoactive drugs.
October NT A: The contract sales amount in the first 10 months was 47.21 billion yuan, a year-on-year decrease of 33%
October NT A (000069) announced on the evening of November 16 that the company achieved a contract sales area of 223,000 square meters and a contract sales amount of 4.24 billion yuan; from January to October, the company achieved a cumulative contract sales area of 2.234 million square meters, a decrease of 35% from the same period last year, and a contract sales amount of 47.21 billion yuan, a decrease of 33% from the same period last year.
[Suspension and Resumption of Trading]
*ST Huayuan: Restructuring matters will be held at the meeting. Stocks will be suspended on November 17
*ST Huayuan (600726) announced on the evening of November 16 that the China Securities Regulatory Commission's Mergers and Acquisition Committee is scheduled to hold the 21st Mergers and Acquisition Committee of 2022 on the morning of November 17 to review the company's issuance of shares to purchase assets and raise supporting funds and related transactions. The company's stock will be suspended from trading from the opening of the market on November 17.
Xin'an Century: plans to acquire 80% of the shares of Pushi Technology for 244 million yuan. It resumed trading on the 17th
Xin'an Century (688201) announced on the evening of November 16 that the company plans to purchase 80% of the shares of Pushi Technology by issuing shares and paying cash. The transaction price is 244 million yuan, of which 239 million yuan is paid by issuing shares. The performance commitment party of this transaction promises that the net profit of Universal Technology in 2022, 2023 and 2024 will not be less than RMB 24 million, RMB 29.5 million and RMB 36.5 million respectively, and the cumulative total of RMB 90 million in three years. After the transaction is completed, the company can quickly expand its business to the military and military industries. The company's stock resumed trading on November 17.
This article comes from the financial industry
